Dimensional Fund Advisors LP decreased its position in UnitedHealth Group Inc (NYSE:UNH) by 2.9% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 3,064,355 shares of the healthcare conglomerate’s stock after selling 92,815 shares during the period. UnitedHealth Group comprises approximately 0.3% of Dimensional Fund Advisors LP’s portfolio, making the stock its 25th biggest holding. Dimensional Fund Advisors LP owned 0.32% of UnitedHealth Group worth $763,368,000 at the end of the most recent quarter.
A number of other institutional investors have also recently bought and sold shares of UNH. BlackRock Inc. raised its holdings in shares of UnitedHealth Group by 3.1% in the 4th quarter. BlackRock Inc. now owns 69,831,381 shares of the healthcare conglomerate’s stock worth $17,396,391,000 after purchasing an additional 2,123,417 shares during the period. Vanguard Group Inc grew its stake in shares of UnitedHealth Group by 1.6% in the third quarter. Vanguard Group Inc now owns 69,342,549 shares of the healthcare conglomerate’s stock valued at $18,447,892,000 after buying an additional 1,073,505 shares in the last quarter. Oregon Public Employees Retirement Fund grew its stake in shares of UnitedHealth Group by 50,446.5% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 53,349,795 shares of the healthcare conglomerate’s stock valued at $214,000 after buying an additional 53,244,249 shares in the last quarter. Northern Trust Corp grew its stake in shares of UnitedHealth Group by 2.5% in the fourth quarter. Northern Trust Corp now owns 11,669,246 shares of the healthcare conglomerate’s stock valued at $2,907,043,000 after buying an additional 288,199 shares in the last quarter. Finally, Canada Pension Plan Investment Board grew its stake in shares of UnitedHealth Group by 2.6% in the fourth quarter. Canada Pension Plan Investment Board now owns 3,246,909 shares of the healthcare conglomerate’s stock valued at $808,802,000 after buying an additional 83,821 shares in the last quarter. 85.76% of the stock is currently owned by institutional investors.
A number of equities research analysts have weighed in on the company. Credit Suisse Group restated a “buy” rating and set a $310.00 price objective on shares of UnitedHealth Group in a research note on Friday, February 8th. ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, February 27th. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, March 19th. SunTrust Banks lowered their price objective on UnitedHealth Group to $300.00 and set a “buy” rating for the company in a research note on Wednesday, April 17th. They noted that the move was a valuation call. Finally, Raymond James lowered their price objective on UnitedHealth Group from $310.00 to $265.00 and set a “strong-buy” rating for the company in a research note on Wednesday, April 17th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $290.84.
In related news, Director Richard T. Burke sold 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, March 12th. The stock was sold at an average price of $245.01, for a total value of $1,225,050.00. Following the sale, the director now owns 182,372 shares of the company’s stock, valued at approximately $44,682,963.72. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Richard T. Burke sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 24th. The stock was sold at an average price of $229.75, for a total value of $2,297,500.00. Following the completion of the sale, the director now directly owns 187,663 shares in the company, valued at approximately $43,115,574.25. The disclosure for this sale can be found here. In the last quarter, insiders sold 27,930 shares of company stock valued at $6,746,683. Insiders own 0.87% of the company’s stock.
Shares of UNH traded up $0.34 during mid-day trading on Wednesday, hitting $242.40. The stock had a trading volume of 3,842,273 shares, compared to its average volume of 4,637,209. The firm has a market cap of $235.33 billion, a price-to-earnings ratio of 18.82, a PEG ratio of 1.33 and a beta of 0.74. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.63. UnitedHealth Group Inc has a fifty-two week low of $208.07 and a fifty-two week high of $287.94.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 EPS for the quarter, topping the consensus estimate of $3.60 by $0.13. The company had revenue of $60.30 billion during the quarter, compared to analyst estimates of $59.72 billion. UnitedHealth Group had a return on equity of 25.07% and a net margin of 5.45%. The business’s revenue was up 9.2% on a year-over-year basis. During the same quarter last year, the firm earned $3.04 EPS. On average, sell-side analysts predict that UnitedHealth Group Inc will post 14.71 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Dimensional Fund Advisors LP Sells 92,815 Shares of UnitedHealth Group Inc (NYSE:UNH)” was first published by Sundance Herald and is owned by of Sundance Herald. If you are reading this article on another publication, it was stolen and republished in violation of United States and international copyright & trademark legislation. The legal version of this article can be accessed at https://sundanceherald.com/2019/05/29/unitedhealth-group-inc-unh-holdings-trimmed-by-dimensional-fund-advisors-lp.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: How much can an individual set aside as a catch-up contribution?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.